Immune Response following Liver Transplantation Compared to Kidney Transplantation: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity and Cytochrome P450 3A5 Genotype Assay

Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients

(2015) Yuichi Muraki et al.   Annals of Transplantation

Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism

(2013) Philippe Durand et al.   PHARMACOGENOMICS

Can Immune Cell Function Assay Identify Patients at Risk of Infection or Rejection? A Meta-Analysis

(2012) Xiaoting Ling et al.   TRANSPLANTATION

Innovative approaches to improve outcomes in transplantation

(2011) Ron Shapiro   Nature Reviews Nephrology

Rejet de la greffe rénale : mécanisme et prévention

(2011) Chehrazade Brick et al.   Nephrologie & Therapeutique

Lack of Association of Immune Cell Function Test With Rejection in Kidney Transplantation

(2011) A. Torío et al.   TRANSPLANTATION PROCEEDINGS

Single Time Point Immune Function Assay (ImmuKnowTM) Testing Does Not Aid in the Prediction of Future Opportunistic Infections or Acute Rejection

(2010) J. Huskey et al.   Clinical Journal of the American Society of Nephrology

Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype

(2010) Shugo Mizuno et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients

(2008) Masahide Fukudo et al.   Pharmacogenetics and Genomics